SM-04755

N/A

Report date: 2022/11/25 17:01:06
NME

Base Information

Drug NameSM-04755
Drug Alias NameSM-04755
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionWnt signalling pathway inhibitors
TargetsNot applicable
Therapy Area/IndicationsTendinopathyPancreatic NeoplasmsLiver Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiosplice Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiosplice Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsTendinopathyPancreatic NeoplasmsLiver Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A